![FDA, NMRA Approves NIBIMA As Herbal Medicine For Coronavirus Treatment -[RELEASED STATEMENT]](https://paullingual.com/wp-content/uploads/2021/02/NIBIMA.jpg "NIBIMA")
Per the document available to PAULLINGUAL.COM bares that the Food Drugs Authority(FDA), the National Medicine Regulatory Agency(NMRA) have jointly approved a herbal medicine known as NIBIMA for COVID-19 treatment.
The organization made this known through a statement released today, 21, February 2021.
The herbal medicine Cryptolepis Sanguinolenta known locally as Nibima has been approved for clinical trials in January 2021.
According to the FDA, researchers at the Kwame Nkrumah University of Science and Technology(KNUST) submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta.
The situation continues that “In search for treatment for ongoing COVID-19 pandemic, researchers from the School of Public Health at the Kwame Nkrumah University of Science and Technology(KNUST) submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta as a potential treatment for COVID-19. This follows results from laboratory studies conducted by KNUST research team which points in the direction of possible clinical benefits.”
Read the full statement below
Leave a Reply